|
1）Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012; 35: 695-701
|
|
|
|
2）Rothwell P, Howard S, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hyperten-sion. Lancet. 2010; 375: 895-905
|
|
|
|
|
|
3）矢野裕一朗，苅尾七臣．ABPMで評価する血圧変動-短期変動．動脈効果予防．2011: 9: 5-10
|
|
|
|
|
|
4）廣岡良隆．血圧変動を抑制する高血圧治療法はあるか？ 動脈効果予防．2011; 9: 75-9
|
|
|
|
|
|
5）甲斐久史，今泉 勉．交感神経系と循環器疾患-over view-. Heart View. 2011; 14: 8-13
|
|
|
|
|
|
6）Kario K. Preceding linkage between a morning surge in blood pressure and small artery remodeling: an indicator of prehypertension? J Hypertens. 2007; 25: 1573-5
|
|
|
|
|
|
7）Parati G, Pomidossi G, Albini F, et al. Rela-tionship of 24-hour blood pressure mean and vari-ability to severity of target-organ damage in hypertension. J Hypertens. 1987; 5: 93-8
|
|
|
|
|
|
8）Alfonso T, Giulia R, Marco Z, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension. 2007; 50: 1-8
|
|
|
|
|
|
9）Eto M, Toba K, Akishita M, et al. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res. 2005; 28: 1-7
|
|
|
|
|
|
10）Kikuya M, Hozawa A, Ohokubo T, et al. Prog-nostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hyper-tension. 2000; 36: 901-6
|
|
|
|
|
|
11）Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994; 24: 793-801
|
|
|
|
|
|
12）Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002; 20: 2183-9
|
|
|
|
|
|
13）Kario K, Picckering T, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003; 107: 1401-6
|
|
|
|
|
|
14）Imai Y, Hozawa A, Ohkubo T, et al. Predicitive values of automated blood pressure measurement: what can we learn from the Japanese population -the Ohasama study. Blood Press Monit. 2001; 6: 335-9
|
|
|
|
|
|
15）Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008; 52: 1045-50
|
|
|
|
|
|
16）Kudo H, Kai H, Kajimoto H, et al. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension. 2009; 54: 832-8
|
|
|
|
|
|
17）Takayama N, Kai H, Kudo H, et al. Simvastatin prevents large blood pressure variability-induced aggravation of cardiac hypertrophy in hyper-tensive rats by inhibiting RhoA/Ras-ERK pathways. Hypertens Res. 2011; 34: 341-7
|
|
|
|
|
|
18）Ueda T, Kai H, Imaizumi T; MAPPY Study Investigators. Losartan/hydrochlorothiazide combination vs. high dose losartan in patients with morning hypertension -- A prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res. 2012; 35: 708-14
|
|
|
|
|
|
19）Kario K, Hoshide S, Shimizu M, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure record-ings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protec-tion (J-TOP) study. J Hypertens. 2010; 28: 1574-83
|
|
|
|
|
|
20）Rothwell P, Howard S, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010; 9: 469-80
|
|
|
|
|
|
21）Webb A, Fischer U, Mehta Z, et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375: 906-15
|
|
|
|
|
|
22）Matsui Y, ORourke MF, Hoshide S, et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension. 2012; 59: 1132-8
|
|
|
|
|